ArticleCPT: pharmacometrics & systems pharmacology2021

Population pharmacokinetics of belantamab mafodotin, a BCMA-targeting agent in patients with relapsed/refractory multiple myeloma.

Chetan Rathi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.